搜尋
Quanterix Corp
QTRX添加自選
4.330USD
-0.010-0.23%
收盤 07/02, 13:00（美東）報價延遲15分鐘
203.77M總市值
虧損本益比TTM
關鍵數據
4.380今開
4.440最高
456.29K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.97%換手率
4.340昨收
4.220最低
1.42M成交額
虧損本益比靜
0.72市淨率
0.00%股息率 TTM
-27.30%ROA
8.77052週最高
0.53量比
-38.53M淨利潤
47.06M總股本
-2.3568每股盈餘TTM
1.37Beta
-34.81%ROE
3.36052週最低
5.07%振幅
42.75%毛利率
203.77M總市值
2.97回報/風險
4.79%風險率
TradingKey Quanterix Corp股票評分
單位: USD 更新時間: 2026-07-02操作建議
Quanterix Corp當前公司基本面數據相對健康，增長潛力較大。當前估值合理，在醫療設備與耗材行業排名100/204位。機構持股佔比非常高，近一月多位分析師給出公司評級為持有。最高目標價為4.33。中期看，股價處於上升通道。近一個月，市場表現較強，技術面和基本面綜合得分較高，較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Quanterix Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
Quanterix Corp亮點
亮點風險
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
利潤高增長
公司淨利潤處於行業前列，最新年度總收入138.90M美元
估值高估
公司最新PE估值-1.84，處於3年歷史高位
機構減倉
最新機構持股42.63M股，環比減少10.46%
史蒂文·科恩持倉
明星投資者史蒂文·科恩持倉，最新持倉123.87K股
分析師目標
基於
3
分析師
持有
評級
4.333
目標均價
-0.15%
漲幅空間
Quanterix Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Quanterix Corp簡介
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
公司代碼QTRX
公司Quanterix Corp
CEOToloue (Masoud)
網址https://www.quanterix.com/
相關品種
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%熱門品種
52837.000
-15.900 (-0.03%)
29661.900
-8.000 (-0.03%)
7506.800
-1.000 (-0.01%)
14956.000
-7.000 (-0.05%)
69583.000
-93.000 (-0.13%)
6407.100
-5.300 (-0.08%)
68.294
-0.389 (-0.57%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4181.290
+6.680 (+0.16%)
常見問題
Quanterix Corp(QTRX)的當前股價是多少？
Quanterix Corp(QTRX)的當前股價是 4.33。
Quanterix Corp 的股票代碼是什麼？
Quanterix Corp的股票代碼是QTRX。
Quanterix Corp股票的52週最高點是多少？
Quanterix Corp股票的52週最高點是8.77。
Quanterix Corp股票的52週最低點是多少？
Quanterix Corp股票的52週最低點是3.36。
Quanterix Corp的市值是多少？
Quanterix Corp的市值是203.77M。
現在Quanterix Corp(QTRX)的股票是買入、持有還是賣出？
根據分析師評級，Quanterix Corp(QTRX)的總體評級為signal_hold，目標價格為4.33。
Quanterix Corp(QTRX)股票的每股收益（EPS TTM）是多少
Quanterix Corp(QTRX)股票的每股收益（EPS TTM）是-2.51。